Figure S9 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma Article Swipe
Alyssa C. Flint
,
Steven P. Angus
,
Waylan Bessler
,
Li Jiang
,
Xiaohong Li
,
Qingbo Lu
,
George E. Sandusky
,
Andrea R. Masters
,
Chi Zhang
,
Gary L. Johnson
,
Jiangang Liu
,
Amit Aggarwal
,
Gregory P. Donoho
,
Melinda D. Willard
,
Shripad V. Bhagwat
,
Steven D. Rhodes
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30708778
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30708778
Kaplan Meier Survival Curve and Tolerability
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Landing Page
- https://doi.org/10.1158/1078-0432.30708778
- https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdf
- OA Status
- gold
- OpenAlex ID
- https://openalex.org/W4416630297
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416630297Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.30708778Digital Object Identifier
- Title
-
Figure S9 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaWork title
- Type
-
articleOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-25Full publication date if available
- Authors
-
Alyssa C. Flint, Steven P. Angus, Waylan Bessler, Li Jiang, Xiaohong Li, Qingbo Lu, George E. Sandusky, Andrea R. Masters, Chi Zhang, Gary L. Johnson, Jiangang Liu, Amit Aggarwal, Gregory P. Donoho, Melinda D. Willard, Shripad V. Bhagwat, Steven D. RhodesList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.30708778Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4416630297 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.30708778 |
| ids.doi | https://doi.org/10.1158/1078-0432.30708778 |
| ids.openalex | https://openalex.org/W4416630297 |
| fwci | |
| type | article |
| title | Figure S9 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | |
| locations[0].id | doi:10.1158/1078-0432.30708778 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.30708778 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5002388430 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5698-9776 |
| authorships[0].author.display_name | Alyssa C. Flint |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alyssa C. Flint |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5067366916 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7655-657X |
| authorships[1].author.display_name | Steven P. Angus |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Steven P. Angus |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5011940249 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0685-9206 |
| authorships[2].author.display_name | Waylan Bessler |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Waylan Bessler |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5049617151 |
| authorships[3].author.orcid | https://orcid.org/0009-0003-6488-1927 |
| authorships[3].author.display_name | Li Jiang |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Li Jiang |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5100767812 |
| authorships[4].author.orcid | https://orcid.org/0009-0000-2728-0565 |
| authorships[4].author.display_name | Xiaohong Li |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Xiaohong Li |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5020630997 |
| authorships[5].author.orcid | https://orcid.org/0009-0005-6786-9100 |
| authorships[5].author.display_name | Qingbo Lu |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Qingbo Lu |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5061385868 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0769-057X |
| authorships[6].author.display_name | George E. Sandusky |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | George E. Sandusky |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5114321199 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-9570-8786 |
| authorships[7].author.display_name | Andrea R. Masters |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Andi R. Masters |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5012408594 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9553-0925 |
| authorships[8].author.display_name | Chi Zhang |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Chi Zhang |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5047612906 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2867-0551 |
| authorships[9].author.display_name | Gary L. Johnson |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Gary L. Johnson |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5080535835 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-2800-077X |
| authorships[10].author.display_name | Jiangang Liu |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Jiangang Liu |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5078360952 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-4800-4046 |
| authorships[11].author.display_name | Amit Aggarwal |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Amit Aggarwal |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5071061160 |
| authorships[12].author.orcid | https://orcid.org/0009-0007-8865-5093 |
| authorships[12].author.display_name | Gregory P. Donoho |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Gregory P. Donoho |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5079993897 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-2937-962X |
| authorships[13].author.display_name | Melinda D. Willard |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Melinda D. Willard |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5003086261 |
| authorships[14].author.orcid | https://orcid.org/0009-0001-1231-9735 |
| authorships[14].author.display_name | Shripad V. Bhagwat |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Shripad V. Bhagwat |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5062014907 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-6551-8631 |
| authorships[15].author.display_name | Steven D. Rhodes |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Steven D. Rhodes |
| authorships[15].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-25T00:00:00 |
| display_name | Figure S9 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T19:05:31.901192 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.30708778 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.30708778 |
| primary_location.id | doi:10.1158/1078-0432.30708778 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S9_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708778/1/files/59833588.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.30708778 |
| publication_date | 2025-11-25 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.and | 4 |
| abstract_inverted_index.Curve | 3 |
| abstract_inverted_index.Meier | 1 |
| abstract_inverted_index.Survival | 2 |
| abstract_inverted_index.<p>Kaplan | 0 |
| abstract_inverted_index.Tolerability</p> | 5 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 16 |
| citation_normalized_percentile |